Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB(1)) Are Neither Obese Nor Diabetic

Multiple lines of evidence implicate the endocannabinoid signaling system in the modulation of metabolic disease. Genetic or pharmacological inactivation of CB(1) in rodents leads to reduced body weight, resistance to diet-induced obesity, decreased intake of highly palatable food, and increased ene...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcus, David J., Zee, Michael L., Davis, Brian J., Haskins, Chris P., Andrews, Mary-Jeanette, Amin, Randa, Henderson-Redmond, Angela N., Mackie, Ken, Czyzyk, Traci A., Morgan, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976987/
https://www.ncbi.nlm.nih.gov/pubmed/27501235
http://dx.doi.org/10.1371/journal.pone.0160462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976987/
https://www.ncbi.nlm.nih.gov/pubmed/27501235
http://dx.doi.org/10.1371/journal.pone.0160462

Ejemplares similares